CPHI Announces 2014 Expert Industry Panel
CPHI Worldwide, organised by UBM Live, announces its initial line up of confirmed expert industry panel members for 2014, building on the huge success of the CPHI annual report launched at CPHI Worldwide in October 2013.
This year’s panel sees the return of nine thought leaders, with further members joining imminently. In addition, this year panel members will also be utilising their market insights and analysis year round in the CPHI Pharma Insights series, which covers individual topics and developments across the industry, including the recently launched R&D and manufacturing reports.
Expertise ranges from API and manufacturing efficiencies (Girish Malhotra) to quality systems and supply chain activities (Sam Venugopal), with insights also provided from some of the sectors biggest names and innovators, such as Piramal’s Vijay Shah. In addition, the panel features regulatory heavyweight, Ajaz Hussain of Wockhardt — renowned for coining the term PAT — who will lend his expertise on establishing and improving drug regulation. Across supply chain issues, the panel will leverage the knowledge of Hedley Rees, whereas Prabir Basu, formerly of the National Institute for Pharmaceutical Technology and Education (NIPTE), will focus on the industry’s approach to innovation.
Regulatory expert, predominantly focussed on the Indian market, Dilip Shah, also returns covering the intellectual property rules around innovation.
Emil Ciurczak, also previously a member of the FDA’s PAT committee and president of Doramaxx Consulting draws up his expertise across PAT, QbD and spectroscopy. Finally, William Botha, a respected trainer and mentor in manufacturing is also retuning to the panel; he is fluent in FDA regulations, including GDP and GMP.
Last year’s report examined a number of major issues and developments across the industry including cost savings through QbD and PAT, to regulatory challenges from a globalised industry, right through to the effect breakthrough drugs such as ADCs will have on overcoming future disease pathologies.
“Last year’s report was a huge success with our experts providing a combined insight into the overall picture of the industry. What is interesting this year is to see the industry's progress, and what new problems or challenges there are. In the first annual report, insights spanned a mixture of practical manufacturing improvements, such as single-use reactors and continuous processing, mixed with regulatory risks and the future potential of breakthrough drugs, such as ADCs, and supply chain issues. Everything from life-saving drugs to an open assessment of where industry risks lay, and culminating in the new emerging business model — with increased partnerships, innovation sharing and consolidation. Furthermore, our experts offered conclusions on the necessary techniques, technologies and a simplified regulatory approach that will simultaneously increase safety and innovation,” commented Chris Kilbee, Group Director Pharma at CPHI.
The 2014 annual report will feature a collection of in-depth essays from each panel member, with experts given carte blanche to prophesize how the industry will look and operate from both an economic and practical perspective. In addition, the CPHI Pharma Insights reports contain a mixture of primary data (industry surveys) and expert comment on what these findings show about the general direction of the industry and any issues they feel need to be addressed.
CPHI is now in the later stages of assembling the panel’s full line-up and plans to announce all participants in the summer, with a few more global heavyweights expected.
Kilbee added: “I am delighted that we have been able to source so many leading figures from within the industry to take part in the panel, as collectively they bring a huge amount of experience and insight. Already the panel’s knowledge spans pharmaceutical ingredients, manufacturing processes, global supply chain issues and regulatory frameworks. One thing they all have in common is a wealth of experience across international markets and a practical approach to problem solving, which will be invaluable in postulating future market dynamics.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance